Persistence of proinflammatory response after severe respiratory syncytial virus disease in children

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 6, 2007, Pages 1547-1550

  Bermejo Martin, Jesus F ^a   Garcia Arevalo, M Carmen ^a   Alonso, Ana ^b   De Lejarazu, Raul O ^b   Pino, Maria ^b   Resino, Salvador ^c   Tenorio, Alberto ^b   Bernardo, David ^a   Leon, Alberto J ^a   Garrote, Jose A ^a,e   Ardura, Julio ^b   Dominguez Gil, Marta ^b   Eiros, Jose M ^b   Blanco Quiros, Alfredo ^a   Munoz Fernandez, M Angeles ^c   Kelvin, David J ^d   Arranz, Eduardo ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HCU   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e HCU Unidad de Investigación   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LETTER; MEDIATOR RELEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RNA VIRUS INFECTION; SYMPTOM;

CHEMOKINES; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFANT; INFLAMMATION MEDIATORS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS;

EID: 34249778959     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.03.014     Document Type: Letter

References (9)

1. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33 (2006) 235-252
2. Martinon-Torres F., Rodriguez-Nunez A., and Martinon-Sanchez J.M. Heliox therapy in infants with acute bronchiolitis. Pediatrics 109 (2002) 68-73
3. Joachimiak M.P., Weissman J.L., and May B.C.H. JColorGrid: software for the visualization of biological measurements. BMC Bioinformatics 7 (2006) 225
4. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Makela M.J., Dakhama A., et al. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med 162 (2000) 380-386
5. Hashimoto K., Durbin J.E., Zhou W., Collins R.D., Ho S.B., Kolls J.K., et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 116 (2005) 550-557
6. Panuska J.R., Merolla R., Rebert N.A., Hoffmann S.P., Tsivitse P., Cirino N.M., et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 96 (1995) 2445-2453
7. Rutigliano J.A., and Graham B.S. Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 173 (2004) 3408-3417
8. Openshaw P.J.M., and Tregoning J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18 (2005) 541-555
9. Oh J.W., Lee H.B., Park I.K., and Kang J.O. Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol 13 (2002) 350-356